This personalized approach aligns with PlexusDx's precision-wellness model: matching your medication, dosing strategy, and supplementation to your individual biology rather than applying a standard protocol to all patients
The academic community has been running the gun-shy version of this program for three years
Sell DR, Lane MA, Obrenovich ME, et al
Interesting to see how much the field is shifting toward exposure sustainability and adherence realism rather than just mechanism complexity
For Medicaid enrollees, unless their state program covers obesity drugs, they are unlikely to afford even the reduced cash prices
Yes, diarrhea is one of the most common side effects, affecting up to 25% of patients in the first 24 weeks